NEW YORK, Oct. 2 – GeneChip-maker Affymetrix (Nasdaq: AFFX) of Santa Clara Calif., said Monday that it would acquire privately-held computational genomics company Neomorphic of Berkeley, Calif., for about $70 million in stock, based on Friday’s close.

The companies anticipate that products resulting from the acquisition will include whole-genome, high-density GeneChip arrays, new data analysis tools, and a series of Internet-accessible information products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.